Guangdong Procapzoom Biosciences Co., Ltd.
Clinical trials sponsored by Guangdong Procapzoom Biosciences Co., Ltd., explained in plain language.
-
New liver cancer treatment begins first human testing
Disease control Not yet recruitingThis is a very early study to check if a new injection called SZ1003 is safe and tolerable for people with advanced liver cancer. It will involve 12 patients whose cancer has continued to grow after trying at least two other standard treatments. The main goal is to find a safe do…
Phase: EARLY_PHASE1 • Sponsor: Guangdong ProCapZoom Biosciences Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
New cell therapy tested for patients Who've tried everything else
Disease control Not yet recruitingThis early-stage study is testing a new cell therapy for people with severe, treatment-resistant myasthenia gravis. Doctors will give participants specially engineered immune cells (called CD19-CAR-NK cells) from a donor to see if they are safe and can help control the disease. T…
Phase: EARLY_PHASE1 • Sponsor: Guangdong ProCapZoom Biosciences Co., Ltd. • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC
-
New cell therapy tested for incurable dry eye disease
Symptom relief Not yet recruitingThis early-stage study is testing whether exosomes—tiny particles released by cells—can safely improve severe dry eye symptoms in people with Sjögren's syndrome. It will involve 12 adults whose eye dryness hasn't improved with standard treatments like artificial tears. Researcher…
Phase: EARLY_PHASE1 • Sponsor: Guangdong ProCapZoom Biosciences Co., Ltd. • Aim: Symptom relief
Last updated Mar 27, 2026 12:41 UTC
-
New lens trial offers hope for Sjögren's dry eye relief
Symptom relief Not yet recruitingThis early-stage study is testing special contact lenses containing stem cells to help people with Sjögren's syndrome who have severe dry eyes that haven't improved with standard treatments. The trial will involve 12 participants to check if the lenses are safe and if they can im…
Phase: EARLY_PHASE1 • Sponsor: Guangdong ProCapZoom Biosciences Co., Ltd. • Aim: Symptom relief
Last updated Mar 25, 2026 14:07 UTC